Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, with the study history otherwise unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedA notice about NIH website updates explains that federal agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.4%

- Check36 days agoChange DetectedThe website footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check43 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the study record information remains unchanged.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision tag updated from v3.6.6 to v3.7.0, indicating a newer build of the study record history UI.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.